本文已被:浏览 168次 下载 169次
投稿时间:2026-05-09 网络发布日期:2026-10-23
投稿时间:2026-05-09 网络发布日期:2026-10-23
中文摘要: 目的 探讨基于免疫指标-临床特征的联合模型的构建及对原发性骨髓纤维化(PMF)患者预后的预测价值,为其精准风险分层的评估和管理提供支持。方法 回顾性选取宁夏医科大学附属自治区人民医院2016年1月至2024年6月收治的PMF患者71例为研究对象。随访1年,根据患者是否恶化、复发或死亡将患者分为预后良好组(n=51)和预后不良组(n=20)。比较两组患者免疫指标[CD4+T细胞、CD8+T细胞、白细胞介素-6(IL-6)、免疫球蛋白(Ig)G、IgA、IgM]和临床资料。采用logistic回归分析上述指标与PMF患者预后的关系,并构建联合模型;采用受试者工作特征(ROC)曲线、Hosmer-Lemeshow 拟合优度检验评估联合模型的预测效能。结果 预后不良组年龄、国际预后积分系统(IPSS)评分、输血依赖比例、骨髓增殖性肿瘤评估总症状量表(MPN-10)评分、CD4+T细胞比例、IL-6、C 反应蛋白(CRP)、乳酸脱氢酶(LDH)、IgA 水平与预后良好组相比,差异有统计学意义(P<0.05)。多因素logistic回归分析结果显示,IPSS评分≥3分、输血依赖以及IL-6、LDH和IgA水平升高与PMF患者预后不良独立相关(P<0.05);联合预测模型为:logit(P)=-6.856+0.812×IPSS 评分(≥3 分)+1.008×输血依赖+0.383×IL-6+0.008×LDH+0.820×IgA;联合预测模型的ROC 曲线下面积为0.923(95%CI:0.860~0.985),Hosmer-Lemeshow 检验结果为χ2=4.812,P=0.777。结论 以免疫指标及临床特征构建的联合模型具有一定临床价值,有望成为对PMF患者预后临床评估的潜在标志物。
Abstract:Objective To explore the construction of a combined model based on immune indicators and clinical characteristics and its value in predicting the prognosis of patients with primary myelofibrosis(PMF),to support precise risk stratification and management. Methods A total of 71 patients with PMF treated at the People’s Hospital of Ningxia Hui Autonomous Region from January 2016 to June 2024 were retrospectively selected as the research subjects.All patients were followed up for 1?year. Patients were divided into a good prognosis group(n=51)and a poor prognosis group(n=20)according to whether the patients deteriorated,relapsed or died. The immune indicators[CD4+ T cells,CD8+ T cells,interleukin - 6(IL - 6),immunoglobulin(Ig)G,IgA,IgM]and clinical data of the two groups were compared. Logistic regression analysis was used to examine the relationship between the above indicators and the prognosis of patients with PMF,and a combined model was constructed. The predictive performance of the combined model was evaluated using receiver operating characteristic(ROC)curve and Hosmer-Lemeshow goodness-of-fit test.Results Compared with the good prognosis group,the poor prognosis group had statistically significant differences in age,score of International Prognostic Scoring System(IPSS),transfusion dependence ratio,score of Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score(MPN-10),percentage of CD4+ T cells,and levels of IL-6,C-reactive protein(CRP),lactate dehydrogenase(LDH)and IgA(P<0.05). Multivariate logistic regression analysis showed that an IPSS score ≥3,transfusion dependence,and elevated levels of IL-6,LDH,and IgA were independently associated with poor prognosis in patients with PMF(P<0.05). The combined predictive model was expressed as:logit(P)= -6.856+0.812×IPSS score(≥3 points)+1.008×transfusion dependence+0.383×IL-6+0.008×LDH+0.820×IgA.The area under the ROC curve of the combined predictive model was 0.923(95% CI:0.860- 0.985). The Hosmer-Lemeshow test yielded a χ2 value of 4.812 with P=0.777. Conclusion The combined model constructed based on immune indicators and clinical characteristics has certain clinical value and holds promise as a potential biomarker for clinical assessment of the prognosis of patients with PMF.
文章编号: 中图分类号:R551.3 文献标志码:A
基金项目:宁夏回族自治区卫生健康委项目(2025-NWSY-A005)
附件
引用文本:
陈俊敏,田娟,薛毅苗,魏玉萍,顾义海,宋丽君.免疫指标-临床特征联合模型对原发性骨髓纤维化患者预后的预测价值[J].中国临床研究,2026,39(10):1542-1545,1550.
陈俊敏,田娟,薛毅苗,魏玉萍,顾义海,宋丽君.免疫指标-临床特征联合模型对原发性骨髓纤维化患者预后的预测价值[J].中国临床研究,2026,39(10):1542-1545,1550.
